Sodium-Glucose Co-Transporter 2 Inhibitors in the Peri-Operative Period: A Warning to All Clinicians

BJU International- United Kingdom

doi 10.1111/bju.14766

Full Text

Abstract

Available in

Categories

Date

May 1, 2019

Authors

Bernhard Riedel

Publisher

Wiley

Related search

Sodium-Glucose Co-Transporter Type-2 Inhibitors: Pharmacology and Peri-Operative Considerations

English

Sodium-Glucose Co-Transporter-2 Inhibitors in Type 1 Diabetes—a Dangerous Ally

US Endocrinology

English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through?

English

Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis

English

Sodium‐glucose Co‐transporter Type‐2 Inhibitors: Is the Message Getting Through? A Reply

English

Early Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes: Study Based on Continuous Glucose Monitoring

Diabetology and Metabolic Syndrome

Internal Medicine

English

The Potential Role of Sodium Glucose Co-Transporter 2 Inhibitors in the Early Treatment of Type 2 Diabetes Mellitus

International Journal of Clinical Practice

English

Sodium-Glucose Co-Transporter 2 Inhibitors: A Review of Their Use in Older People With Type 2 Diabetes Mellitus

Journal of Pharmacy Practice and Research

English

Pdb1 - Acute Renal Outcomes With Sodium Glucose Co-Transporter 2 Inhibitors- Real World Data Analysis

Value in Health

Occupational Health

English